Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exact Sciences Corporation    EXAS

EXACT SCIENCES CORPORATION

(EXAS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
103.02(c) 99.61(c) 107.09(c) 109.7(c) 108.415 Last
1 195 985 1 030 478 1 545 768 1 589 890 532 321 Volume
-3.85% -3.31% +7.51% +2.44% -1.17% Change
More quotes
Financials (USD)
Sales 2020 1 347 M - -
Net income 2020 -341 M - -
Net Debt 2020 402 M - -
P/E ratio 2020 -49,4x
Yield 2020 -
Sales 2021 1 836 M - -
Net income 2021 -208 M - -
Net Debt 2021 457 M - -
P/E ratio 2021 -87,1x
Yield 2021 -
Capitalization 16 473 M 16 473 M -
EV / Sales 2020 12,5x
EV / Sales 2021 9,22x
Nbr of Employees 4 110
Free-Float 99,0%
More Financials
Company
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect... 
More about the company
Notations Surperformance© of Exact Sciences Corporation
Trading Rating : Investor Rating :
More Ratings
All news about EXACT SCIENCES CORPORATION
10/07Pfizer Will Continue Helping Exact Sciences With Cologuard Promotion Through ..
DJ
09/21EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
07/31EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
07/30EXACT SCIENCES : 2Q Earnings Snapshot
AQ
05/06EXACT SCIENCES : 1Q Earnings Snapshot
AQ
05/06EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
04/24EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
03/15EXACT SCIENCES : Message from Chairman & CEO, Kevin Conroy
PU
03/11EXACT SCIENCES : Fight colorectal cancer reciveces grant from exact sciences to ..
PU
03/04EXACT SCIENCES : SEC Filing (424B7)
PU
02/21EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
02/19EXACT SCIENCES : SEC Filing - CT ORDER
PU
02/11EXACT SCIENCES : 4Q Earnings Snapshot
AQ
02/06EXACT SCIENCES CORPORATION : annual earnings release
01/31EXACT SCIENCES CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal..
AQ
More news
News in other languages on EXACT SCIENCES CORPORATION
02/06EXACT SCIENCES CORPORATION : Veröffentlichung des Jahresergebnisses
02/06EXACT SCIENCES CORPORATION : publication des résultats annuels
2019STOCK MARKET PARIS : Attention, semaine très chargée !
2019EN DIRECT DES MARCHES : Sanofi, Airbus, Air France KLM, CNP, Refinitiv, Mylan..
2017EXACT SCIENCES CORPORATION : Veröffentlichung des Halbjahresergebnisses
More news
Chart EXACT SCIENCES CORPORATION
Duration : Period :
Exact Sciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXACT SCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Average target price 119,00 $
Last Close Price 109,70 $
Spread / Highest target 27,6%
Spread / Average Target 8,48%
Spread / Lowest Target -2,46%
EPS Revisions
Managers
NameTitle
Kevin T. Conroy Chairman, President & Chief Executive Officer
Ana Hooker Senior Vice President-Operations
Jeffrey Thomas Elliott Chief Financial Officer
Graham Peter Lidgard Chief Science Officer, SVP-Research & Development
Sandra Statz SVP-Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
EXACT SCIENCES CORPORATION18.62%16 473
GUARDANT HEALTH, INC.34.00%10 431
BGI GENOMICS CO., LTD.93.35%7 868
ADAPTIVE BIOTECHNOLOGIES CORPORATION65.44%6 722
SEEGENE INC--.--%6 083
INVITAE CORPORATION180.60%5 965